Sonnet BioTherapeutics Holdings Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Jun 23 | BuyUS$7,000 | Susan Dexter | Individual | 454.55 | US$15.40 | |
30 May 23 | BuyUS$10,883 | Albert Dyrness | Individual | 1,057.04 | US$10.30 | |
17 May 23 | BuyUS$5,800 | Nailesh Bhatt | Individual | 1,136.36 | US$5.10 | |
15 May 23 | BuyUS$82,867 | Pankaj Mohan | Individual | 16,890.89 | US$4.91 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 2,094 | 0.0682% |
Institutions | 97,824 | 3.19% |
Individual Insiders | 361,767 | 11.8% |
General Public | 2,607,831 | 85% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 233.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
198,300 | US$351.0k | -14.2% | no data | |||
77,273 | US$136.8k | 0% | no data | |||
62,572 | US$110.8k | 122% | no data | |||
43,749 | US$77.4k | 130% | no data | |||
29,447 | US$52.1k | 0% | no data | |||
15,696 | US$27.8k | 21,400% | no data | |||
14,726 | US$26.1k | 0.68% | no data | |||
9,159 | US$16.2k | 19.7% | no data | |||
2,094 | US$3.7k | 0% | no data | |||
1,830 | US$3.2k | -0.05% | no data | |||
1,530 | US$2.7k | 0% | no data | |||
1,225 | US$2.2k | -0.08% | no data | |||
1,145 | US$2.0k | 0% | no data | |||
1,087 | US$1.9k | 185% | no data | |||
787 | US$1.4k | 0% | no data | |||
594 | US$1.1k | 0% | no data | |||
322 | US$569.9 | 0% | no data | |||
61 | US$108.1 | -57% | no data | |||
45 | US$79.9 | 0% | no data | |||
21 | US$36.9 | 90.9% | no data | |||
19 | US$33.7 | 0% | no data | |||
3 | US$5.4 | 0% | no data |